1064 related articles for article (PubMed ID: 16303268)
21. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
22. Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo KF; Chang EH
Trends Biotechnol; 2008 Oct; 26(10):552-8. PubMed ID: 18722682
[TBL] [Abstract][Full Text] [Related]
23. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery.
Li R; Li X; Xie L; Ding D; Hu Y; Qian X; Yu L; Ding Y; Jiang X; Liu B
Int J Pharm; 2009 Sep; 379(1):158-66. PubMed ID: 19524653
[TBL] [Abstract][Full Text] [Related]
25. Polysaccharide-decorated nanoparticles.
Lemarchand C; Gref R; Couvreur P
Eur J Pharm Biopharm; 2004 Sep; 58(2):327-41. PubMed ID: 15296959
[TBL] [Abstract][Full Text] [Related]
26. Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles.
Thierry B; Zimmer L; McNiven S; Finnie K; Barbé C; Griesser HJ
Langmuir; 2008 Aug; 24(15):8143-50. PubMed ID: 18590299
[TBL] [Abstract][Full Text] [Related]
27. In vitro cytotoxicity, hemolysis assay, and biodegradation behavior of biodegradable poly(3-hydroxybutyrate)-poly(ethylene glycol)-poly(3-hydroxybutyrate) nanoparticles as potential drug carriers.
Chen C; Cheng YC; Yu CH; Chan SW; Cheung MK; Yu PH
J Biomed Mater Res A; 2008 Nov; 87(2):290-8. PubMed ID: 18181106
[TBL] [Abstract][Full Text] [Related]
28. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
Ben-Shabat S; Kumar N; Domb AJ
Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
[TBL] [Abstract][Full Text] [Related]
29. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
30. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
31. Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers.
Pressly ED; Rossin R; Hagooly A; Fukukawa K; Messmore BW; Welch MJ; Wooley KL; Lamm MS; Hule RA; Pochan DJ; Hawker CJ
Biomacromolecules; 2007 Oct; 8(10):3126-34. PubMed ID: 17880180
[TBL] [Abstract][Full Text] [Related]
32. Preparation of monodisperse and size-controlled poly(ethylene glycol) hydrogel nanoparticles using liposome templates.
An SY; Bui MP; Nam YJ; Han KN; Li CA; Choo J; Lee EK; Katoh S; Kumada Y; Seong GH
J Colloid Interface Sci; 2009 Mar; 331(1):98-103. PubMed ID: 19081576
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
34. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
Kim HR; Andrieux K; Delomenie C; Chacun H; Appel M; Desmaële D; Taran F; Georgin D; Couvreur P; Taverna M
Electrophoresis; 2007 Jul; 28(13):2252-61. PubMed ID: 17557357
[TBL] [Abstract][Full Text] [Related]
35. Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors.
Lu J; Shi M; Shoichet MS
Bioconjug Chem; 2009 Jan; 20(1):87-94. PubMed ID: 19099361
[TBL] [Abstract][Full Text] [Related]
36. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
37. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
38. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.
Chambers E; Mitragotri S
J Control Release; 2004 Nov; 100(1):111-9. PubMed ID: 15491815
[TBL] [Abstract][Full Text] [Related]
39. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.
Reddy ST; Rehor A; Schmoekel HG; Hubbell JA; Swartz MA
J Control Release; 2006 May; 112(1):26-34. PubMed ID: 16529839
[TBL] [Abstract][Full Text] [Related]
40. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.
Kim HR; Andrieux K; Gil S; Taverna M; Chacun H; Desmaële D; Taran F; Georgin D; Couvreur P
Biomacromolecules; 2007 Mar; 8(3):793-9. PubMed ID: 17309294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
